CONSOLIDATED STATEMENTS OF CASH FLOWS $ in Thousands	12 Months Ended
	Jan. 31, 2019 USD ($)	Jan. 31, 2018 USD ($)	Jan. 31, 2017 USD ($)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 37,510	$ 44,912	$ 39,518
Depreciation	24,828	21,462	19,519
Stock based compensation expense	669	1,641	1,314
Income from equity method investments	(1,536)	(3,232)	(6,144)
Dividends received from equity method investments	4,010	6,516	7,018
Interest income from investments	(1,077)
Loss (gain) on sale of investment		13	(192)
Loss (gain) on disposal of real estate and property and equipment	104	192	(328)
Deferred income tax	(23,364)	(18,605)	3,043
Changes in assets and liabilities:
Accounts receivable	1,535	(1,089)	(2,535)
Inventory	2,278	(3,649)	121
Prepaid expenses and other assets	5,217	(1,170)	(1,357)
Income taxes refundable	(1,083)	(5,542)	4,184
Accounts payable-trade	339	(1,705)	36
Accrued expenses and other liabilities	(1,499)	1,225	4,912
Net cash provided by operating activities	47,931	40,969	69,109
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(10,775)	(24,017)	(14,208)
Purchase of short-term investment	(125,989)
Sale of short-term investments	112,091
Acquisition of business, net of cash acquired		(12,049)
Proceeds from sale of investment		64	4,492
Proceeds from sale of real estate and property and equipment		104	1,511
Repayment of note receivable	27	26	24
Restricted investments and deposits	5	150	510
Net cash used in investing activities	(24,641)	(35,722)	(7,671)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments to noncontrolling interests holders	(4,489)	(3,529)	(3,842)
Capital contributions from minority investor	524	918
Treasury stock acquired	(21,855)		(4,709)
Net cash used in financing activities	(25,820)	(2,611)	(8,551)
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	(2,530)	2,636	52,887
CASH, CASH EQUIVALENTS AND RESTRICTED CASH-Beginning of year	191,342	188,706	135,819
CASH, CASH EQUIVALENTS AND RESTRICTED CASH-End of year	188,812	191,342	188,706
Non cash financing activities-Equity awards issued	1,473	1,195	1,095
Non cash financing activities-Equity awards accrued	487	1,485	1,217
Non cash investing activities-Accrued capital expenditures		1,149	342
Cash and cash equivalents	188,531	190,988	188,576
Restricted cash	281	354	130
Cash, cash equivalents and restricted cash, end of period	$ 188,812	$ 191,342	$ 188,706